Ryan Lake - Jul 8, 2021 Form 4 Insider Report for Recro Pharma, Inc. (SCTL)

Role
Chief Financial Officer
Signature
By: /s/ Ryan D. Lake
Stock symbol
SCTL
Transactions as of
Jul 8, 2021
Transactions value $
-$10,137
Form type
4
Date filed
7/13/2021, 06:03 AM
Previous filing
Jun 8, 2021
Next filing
Nov 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Tax liability -$10.1K -5.17K -1.37% $1.96 373K Jul 8, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.